Professor Adam Mead joins Oxford Cancer leadership team
Congratulations to Adam Mead, who has been appointed Director of Oxford Cancer. Professor Mead joins Professors Mark Middleton and Tim Elliott in leading Oxford’s interdisciplinary cancer research community.
Read more
MRC Translational Immune Discovery Unit
Pioneering the future in the study of human immunity to uncover the molecular pathways driving immune-mediated diseases.
MRC Molecular Haematology Unit
Understanding how mature blood cells are normally made from stem cells and how this is perturbed in common blood disorders.
Centre for Computational Biology
Using computational biology to help understand complex biological systems and combat a range of human diseases.
Latest publications
TiO2 Alternative Coatings for Ferric Pyrophosphate Premixes: Stability and Bioaccessibility Relative to Ferrous Fumarate
Journal article
Teichman DL. et al, (2026), Innovative Food Science and Emerging Technologies, 111
Lethal plague outbreaks in Lake Baikal hunter-gatherers 5,500 years ago
Journal article
Macleod R. et al, (2026), Nature, 654, 697 - 705
Development of a recombinant single-cycle influenza viral vector as an intranasal vaccine against SARS-CoV-2.
Journal article
Munro J. et al, (2026), Sci Rep
Positive allosteric modulator selective for adult muscle nicotinic acetylcholine receptor.
Journal article
Webster RG. et al, (2026), Proc Natl Acad Sci U S A, 123
Transcriptomic analysis of tissue-resident memory T cells of the fallopian tube reveals a precursor immune surveillance network for ovarian cancer prevention
Journal article
AHMED A., (2026), Nature Communications
Upcoming Seminars
Inflammatory bowel disease and neutralizing anti-IL10 autoantibodies
Friday, 19 June 2026, 9.15am to 10.15am
Speaker(s): Dr Nima Gharahdaghi, Uhlig Group, University of Oxford, Pai-Jui Yeh, Uhlig Group, University of Oxford
Series: MRC TIDU Friday Morning Lab Meetings
Publishing your Research at Cell Press
Thursday, 25 June 2026, 12pm to 1pm
Speaker(s): Judith Nicholson, PhD (Cell Press)
From Naïve and CDT4 T Cell Diversity to Therapeutic Design
Friday, 26 June 2026, 9.15am to 10.15am
Speaker(s): Prof. Ronjon Chakraverty, University of Oxford
Series: MRC TIDU Friday Morning Lab Meetings
Constrained B-cell development promotes malignant transformation
Monday, 29 June 2026, 11am to 12pm
Speaker(s): Robin Thiele (German Cancer Research Center (DKFZ))